Vacha (Calamus) for Cognitive Function

Research suggests that Acorus calamus and its primary bioactive constituents, alpha-asarone and beta-asarone, demonstrate notable cognitive and neuroprotective properties across a substantial body of preclinical literature. Studies indicate that these compounds have shown anti-amnesic and anticholinesterase activities in animal models, with beta-asarone in particular appearing to improve learning and memory in rodent models of Alzheimer's disease and vascular dementia through several proposed mechanisms, including regulation of mitophagy pathways and activation of the cAMP/PKA/CREB signaling pathway. The available evidence base consists predominantly of animal studies, mechanistic reviews, and traditional Ayurvedic literature reviews rather than human clinical trials, which represents a meaningful limitation when drawing conclusions about efficacy in humans. While the convergence of traditional use records spanning thousands of years and modern pharmacological findings is notable, the absence of rigorous randomized controlled trials in human populations means that the current evidence, though directionally consistent and supportive, should be considered preliminary.